Celcuity price to book ratio CELC

Market value divided by the book value of the company's net assets, since 2017.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 84.5×; Aug 2026
9-year median: 5.1×
9-year range: 1.2× to 126×
Peer median: 6.7×

Celcuity's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.

It was last meaningful in Aug 2026, at 84.5×.

On the days it had one over the last 9 years, its median was 5.1×, from 1.2× in May 2022 to 126× in May 2026.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	84.5×	39.8×	126×
2025	40.5×	2.3×	73.8×
2024	3.4×	3.0×	4.8×
2023	3.8×	1.5×	4.3×
2022	5.0×	1.2×	5.0×
2021	2.6×	2.6×	24.4×
2020	6.9×	2.7×	8.2×
2019	4.9×	4.9×	10.7×
2018	8.9×	4.7×	10.6×
2017	5.8×	5.6×	5.9×

Against its peers

Companies in Medical - Diagnostics & Research nearest Celcuity's size, closest first, today.

Company	Price to book ratio
CELCCelcuity	n/m
CDNACareDx	8.4×
VCYTVeracyte	2.8×
BLLNBillionToOne	9.5×
LNTHLantheus	5.0×
CAICaris Life Sciences	15.3×
BIOBio-Rad Laboratories	1.4×
RVTYRevvity	2.5×
MEDPMedpace	43.1×
NRCNRC Health	74.1×
LHLabcorp	3.1×
Peer median	6.7×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Celcuity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.